1887
Research Open Access
Like 0

Abstract

Background

Suriname, a country endemic for dengue virus (DENV), is a popular destination for Dutch travellers visiting friends and relatives and tourist travellers. Chikungunya and Zika virus (CHIKV, ZIKV) were introduced in 2014 and 2015, respectively. Data on infection risks among travellers are limited.

Aim

We aimed to prospectively study incidence rate (IR) and determinants for DENV, ZIKV and CHIKV infection in adult travellers to Suriname from 2014 through 2017.

Methods

Participants kept a travel diary and were tested for anti-DENV, anti-ZIKV and anti-CHIKV IgG antibodies (Euroimmun). Selected samples were subjected to an in-house DENV and ZIKV PRNT50. The IR (infections/1,000 person-months of travel) and IR ratio and determinants for infection were calculated.

Results

Travel-acquired infections were found in 21 of 481 participants: 18 DENV, four ZIKV and two CHIKV, yielding an IR of 47.0 (95% CI: 29.6–74.6), IR of 11.6 (95% CI: 4.4–31.0) and IR of 5.6 (95% CI: 1.4–22.2)/1,000 person-months. In nine DENV and three ZIKV infected participants, infections were PRNT50-confirmed, yielding a lower IR of 23.3 (95% CI: 12.1–44.8) and an IR of 8.4 (95% CI: 2.7–26.1) per 1,000 person-months. Tourist travel was associated with DENV infection. ZIKV and CHIKV infections occurred soon after their reported introductions.

Conclusions

Despite an overestimation of serologically confirmed infections, Dutch travellers to Suriname, especially tourists, are at substantial risk of DENV infection. As expected, the risk of contracting ZIKV and CHIKV was highest during outbreaks. Cross-reaction and potential cross-protection of anti-DENV and -ZIKV antibodies should be further explored.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2023.28.2.2200344
2023-01-12
2024-12-22
/content/10.2807/1560-7917.ES.2023.28.2.2200344
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/28/2/eurosurv-28-2-3.html?itemId=/content/10.2807/1560-7917.ES.2023.28.2.2200344&mimeType=html&fmt=ahah

References

  1. Bovée L, Schreijer A. Jaarverslag 2018. Team Algemene Infectieziekten GGD Amsterdam. [Annual report 2018.] Amsterdam: Department of infectious diseases, the Public Health Service Amsterdam; 2018. Dutch. Available from: https://www.ggd.amsterdam.nl/publish/pages/473215/jaarverslag_2018_aiz_def_1.pdf
  2. Statistics Netherlands’ database (Centraal Bureau van de Statistiek). Arrivals and departures from Schiphol Airport, the Netherlands, to Zanderij Airport, Suriname. 2019. Dutch. Available from: https://opendata.cbs.nl/#/CBS/nl/dataset/83435NED/table?ts=1603369256990
  3. Algemeen Bureau voor de Statistiek (ABS). [Office for General Statistics]. Demographic data 2013-2016. Paramaribo: ABS; 2017. Available from: https://statistics-suriname.org/wp-content/uploads/2019/09/DEMOGRAFISCHE-DATA-2013-2016.pdf
  4. Codrington J, Roosblad J, Baidjoe A, Holband N, Adde A, Kazanji M, et al. Zika virus outbreak in Suriname, a report based on laboratory surveillance data. PLoS Curr. 2018;10:ecurrents.outbreaks.ff0f6190d5431c2a2e824255eaeaf339. PMID: 29896441 
  5. Pan American Health Organization (PAHO). Number of reported cases of chikungunya fever in the Americas, by country or territory with autochthonous transmission 2013-2014. Washington, D.C.: PAHO; 2015. Available from: https://www.paho.org/hq/dmdocuments/2014/2014-jul-11-cha-CHIKV-authoch-imported-cases-ew-28.pdf
  6. Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Primers. 2016;2(1):16055.  https://doi.org/10.1038/nrdp.2016.55  PMID: 27534439 
  7. Olivero RM, Hamer DH, MacLeod WB, Benoit CM, Sanchez-Vegas C, Jentes ES, et al. dengue virus seroconversion in travelers to dengue-endemic areas. Am J Trop Med Hyg. 2016;95(5):1130-6.  https://doi.org/10.4269/ajtmh.16-0159  PMID: 27573631 
  8. World Health Organization (WHO). Dengue and severe dengue. Geneva: WHO; 2017. Available from: "http://www.who.int/mediacentre/factsheets/fs117/en/"https://apps.who.int/mediacentre/factsheets/fs117/en/index.html
  9. Overbosch FW, van den Hoek A, Schinkel J, Sonder GJ. High prevalence of previous dengue virus infection among first-generation Surinamese immigrants in the Netherlands. BMC Infect Dis. 2014;14(1):493.  https://doi.org/10.1186/1471-2334-14-493  PMID: 25209195 
  10. de Gier B, Suryapranata FS, Croughs M, van Genderen PJ, Keuter M, Visser LG, et al. Increase in imported malaria in the Netherlands in asylum seekers and VFR travellers. Malar J. 2017;16(1):60.  https://doi.org/10.1186/s12936-017-1711-5  PMID: 28148300 
  11. Leder K, Tong S, Weld L, Kain KC, Wilder-Smith A, von Sonnenburg F, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43(9):1185-93.  https://doi.org/10.1086/507893  PMID: 17029140 
  12. Whelan J, Sonder G, van den Hoek A. Declining incidence of hepatitis A in Amsterdam (The Netherlands), 1996-2011: second generation migrants still an important risk group for virus importation. Vaccine. 2013;31(14):1806-11.  https://doi.org/10.1016/j.vaccine.2013.01.053  PMID: 23395735 
  13. Reizigersadvisering LC. (LCR). [National Coordination Centre for Traveler' Health Advice]. Landelijke protocollen reizigersadvisering. [National guidelines for traveller health advice]. Amsterdam: LCR; 2008. Dutch. Available from: https://www.mijnlcr.nl
  14. Euroimmun. Anti-dengue virus ELISA (IgG). Lübeck: Euroimmun; 2019.
  15. Prat CM, Flusin O, Panella A, Tenebray B, Lanciotti R, Leparc-Goffart I. Evaluation of commercially available serologic diagnostic tests for chikungunya virus. Emerg Infect Dis. 2014;20(12):2129-32.  https://doi.org/10.3201/eid2012.141269  PMID: 25418184 
  16. Euroimmun. Anti-Zika Virus ELISA (IgG). Lübeck: Euroimmun; 2017. Available from: https://www.euroimmun.com/documents/Indications/Infections/Zika-virus/EI_2668_D_UK_A.pdf
  17. Roehrig JT, Hombach J, Barrett AD. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol. 2008;21(2):123-32.  https://doi.org/10.1089/vim.2008.0007  PMID: 18476771 
  18. Pan American Health Organization (PAHO), World Health Organization (WHO). Zika - epidemiological report Suriname. Washington, D.C.: PAHO/WHO; 2017. Available from: https://www.paho.org/en/documents/zika-epidemiological-report-suriname
  19. van Genderen FT, Krishnadath I, Sno R, Grunberg MG, Zijlmans W, Adhin MR. First chikungunya outbreak in Suriname; clinical and epidemiological features. PLoS Negl Trop Dis. 2016;10(4):e0004625.  https://doi.org/10.1371/journal.pntd.0004625  PMID: 27082985 
  20. Baaten GG, Sonder GJ, Zaaijer HL, van Gool T, Kint JA, van den Hoek A. Travel-related dengue virus infection, The Netherlands, 2006-2007. Emerg Infect Dis. 2011;17(5):821-8.  https://doi.org/10.3201/eid1705.101125  PMID: 21529390 
  21. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheim-van Dillen PM, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health. 2002;7(4):331-8.  https://doi.org/10.1046/j.1365-3156.2002.00864.x  PMID: 11952949 
  22. Leder K, Mutsch M, Schlagenhauf P, Luxemburger C, Torresi J. Seroepidemiology of dengue in travellers: a paired sera analysis. Travel Med Infect Dis. 2013;11(4):210-3.  https://doi.org/10.1016/j.tmaid.2013.06.008  PMID: 23890678 
  23. Potasman I, Srugo I, Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis. 1999;5(6):824-7.  https://doi.org/10.3201/eid0506.990615  PMID: 10603220 
  24. Ratnam I, Black J, Leder K, Biggs BA, Matchett E, Padiglione A, et al. Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia. Eur J Clin Microbiol Infect Dis. 2012;31(6):1203-10.  https://doi.org/10.1007/s10096-011-1429-1  PMID: 21983919 
  25. Overbosch FW, Schinkel J, Stolte IG, Prins M, Sonder GJB. Dengue virus infection among long-term travelers from the Netherlands: A prospective study, 2008-2011. PLoS One. 2018;13(2):e0192193.  https://doi.org/10.1371/journal.pone.0192193  PMID: 29415063 
  26. Brathwaite Dick O, San Martín JL, Montoya RH, del Diego J, Zambrano B, Dayan GH. The history of dengue outbreaks in the Americas. Am J Trop Med Hyg. 2012;87(4):584-93.  https://doi.org/10.4269/ajtmh.2012.11-0770  PMID: 23042846 
  27. Hamer D, Lichtveld M. Spatial distribution of epidemiological cases of dengue fever in Suriname, 2001-2012. West Indian Med J. 2015;64(4):344-50. PMID: 26624585 
  28. Pan American Health Organization (PAHO). Reported cases of dengue fever in the Americas. By country or territory. Washington D.C.: PAHO. [Accessed: 22 Oct 2020]. Available from: https://www3.paho.org/data/index.php/en/mnu-topics/indicadores-dengue-en/dengue-nacional-en/252-dengue-pais-ano-en.html
  29. Perez F, Llau A, Gutierrez G, Bezerra H, Coelho G, Ault S, et al. The decline of dengue in the Americas in 2017: discussion of multiple hypotheses. Trop Med Int Health. 2019;24(4):442-53.  https://doi.org/10.1111/tmi.13200  PMID: 30624838 
  30. Borchering RK, Huang AT, Mier-Y-Teran-Romero L, Rojas DP, Rodriguez-Barraquer I, Katzelnick LC, et al. Impacts of Zika emergence in Latin America on endemic dengue transmission. Nat Commun. 2019;10(1):5730.  https://doi.org/10.1038/s41467-019-13628-x  PMID: 31844054 
  31. Overbosch FW, Elfrink F, Schinkel J, Sonder GJB. No chikungunya virus infections among Dutch long-term travellers to (sub)tropical countries: a prospective study 2008-2011. BMC Infect Dis. 2019;19(1):196.  https://doi.org/10.1186/s12879-019-3819-4  PMID: 30808283 
  32. Huits R, Van Den Bossche D, Eggermont K, Lotgering E, Feyens AM, Potters I, et al. Incidence of Zika virus infection in a prospective cohort of Belgian travellers to the Americas in 2016. Int J Infect Dis. 2019;78:39-43.  https://doi.org/10.1016/j.ijid.2018.10.010  PMID: 30368020 
  33. European Centre for Disease Prevention and Control and European Safety Authority. Autochthonous transmission of dengue virus in mainland EU/EEA, 2010-present 2022 . Available from: https://www.ecdc.europa.eu/en/all-topics-z/dengue/surveillance-and-disease-data/autochthonous-transmission-dengue-virus-eueea
  34. European Centre for Disease Prevention and Control (ECDC). Autochthonous transmission of chikungunya virus in mainland EU/EEA, 2007–present 2017. Stockholm: ECDC. [Accessed: 7 September 2022]. Available from: https://www.ecdc.europa.eu/en/all-topics-z/chikungunya-virus-disease/surveillance-threats-and-outbreaks/autochthonous
  35. European Centre for Disease Prevention and Control (ECDC). Aedes albopictus - current known distribution: March 2021. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/aedes-albopictus-current-known-distribution-march-2021
  36. Monge S, García-Ortúzar V, López Hernández B, Lopaz Pérez MA, Delacour-Estrella S, Sánchez-Seco MP, et al. Characterization of the first autochthonous dengue outbreak in Spain (August-September 2018). Acta Trop. 2020;205:105402.  https://doi.org/10.1016/j.actatropica.2020.105402  PMID: 32088276 
  37. Tomasello D, Schlagenhauf P. Chikungunya and dengue autochthonous cases in Europe, 2007-2012. Travel Med Infect Dis. 2013;11(5):274-84.  https://doi.org/10.1016/j.tmaid.2013.07.006  PMID: 23962447 
  38. Calba C, Guerbois-Galla M, Franke F, Jeannin C, Auzet-Caillaud M, Grard G, et al. Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017. Euro Surveill. 2017;22(39):17-00647.  https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00647  PMID: 29019313 
  39. Vermeulen TD, Reimerink J, Reusken C, Giron S, de Vries PJ. Autochthonous dengue in two Dutch tourists visiting Département Var, southern France, July 2020. Euro Surveill. 2020;25(39):2001670.  https://doi.org/10.2807/1560-7917.ES.2020.25.39.2001670  PMID: 33006305 
  40. Lazzarini L, Barzon L, Foglia F, Manfrin V, Pacenti M, Pavan G, et al. First autochthonous dengue outbreak in Italy, August 2020. Euro Surveill. 2020;25(36):2001606.  https://doi.org/10.2807/1560-7917.ES.2020.25.36.2001606  PMID: 32914745 
  41. Riccardo F, Venturi G, Di Luca M, Del Manso M, Severini F, Andrianou X, et al. Secondary autochthonous outbreak of chikungunya, southern Italy, 2017. Emerg Infect Dis. 2019;25(11):2093-5.  https://doi.org/10.3201/eid2511.180949  PMID: 31625839 
  42. Montoya M, Collins M, Dejnirattisai W, Katzelnick LC, Puerta-Guardo H, Jadi R, et al. Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas. J Infect Dis. 2018;218(4):536-45.  https://doi.org/10.1093/infdis/jiy164  PMID: 29618091 
  43. Rodriguez-Barraquer I, Costa F, Nascimento EJM, Nery N, Castanha PMS, Sacramento GA, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019;363(6427):607-10.  https://doi.org/10.1126/science.aav6618  PMID: 30733412 
  44. Petzold S, Agbaria N, Deckert A, Dambach P, Winkler V, Drexler JF, et al. Congenital abnormalities associated with Zika virus infection-Dengue as potential co-factor? A systematic review. PLoS Negl Trop Dis. 2021;15(1):e0008984.  https://doi.org/10.1371/journal.pntd.0008984  PMID: 33395432 
  45. Katzelnick LC, Narvaez C, Arguello S, Lopez Mercado B, Collado D, Ampie O, et al. Zika virus infection enhances future risk of severe dengue disease. Science. 2020;369(6507):1123-8.  https://doi.org/10.1126/science.abb6143  PMID: 32855339 
  46. Hassing RJ, Leparc-Goffart I, Blank SN, Thevarayan S, Tolou H, van Doornum G, et al. Imported Mayaro virus infection in the Netherlands. J Infect. 2010;61(4):343-5.  https://doi.org/10.1016/j.jinf.2010.06.009  PMID: 20600300 
  47. Powers AM, Aguilar PV, Chandler LJ, Brault AC, Meakins TA, Watts D, et al. Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg. 2006;75(3):461-9.  https://doi.org/10.4269/ajtmh.2006.75.461  PMID: 16968922 
/content/10.2807/1560-7917.ES.2023.28.2.2200344
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error